TROPHIT1—a Randomized, Open-Label, Multicenter, Phase II/III Trial of Sacituzumab Govitecan Compared to Standard of Care in Metastatic Colorectal Cancer Patients
ESMO Gastrointestinal Oncology(2025)
关键词
TROP2,clinical trial,resistance,patient-reported outcome,reverse translation
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要